InvestorsHub Logo
Followers 48
Posts 12049
Boards Moderated 0
Alias Born 09/12/2017

Re: Chess Master post# 167843

Wednesday, 05/26/2021 2:42:25 AM

Wednesday, May 26, 2021 2:42:25 AM

Post# of 233273
CYDY grasping at straws- Leronlimab in Combination With Standard of Care for Critically Ill Patients
https://clinicaltrials.gov/ct2/show/NCT04901689?term=leronlimab&draw=2&rank=3

Leronlimab in Combination With Standard of Care for Moderately Ill Patients
https://www.clinicaltrials.gov/ct2/show/NCT04901676?term=leronlimab&draw=2&rank=2

So now CYDY trying to piggyback with other drugs to get approved? "Wonder drug" cant stand on its own to feet and go it alone?

What a joke...its over.

Covid 19 pneumonia already figured out with an affordable and widely available drug- Dexamethasone

patients who now require hospital admission have around an 80 percent chance of survival.

Professor Jenkins said anti-inflammatory treatment has shown to be crucial in improving positive outcomes in COVID-19 pneumonia and respiratory failure, specifically, dexamethasone. Dexamethasone is an affordable glucocorticosteroid (a class of steroid hormone) that is widely available.

"This was a crucial element that suddenly gave everybody a leg up in terms of the possibility of improved survival. That combined with what has been learnt about supplemental oxygen, respiratory support, and the risks that contributed to a greater likelihood of a worse outcome being managed more effectively has really been the key contributor to reduced mortality rates from COVID-19. It is still a truly devastating disease in circumstances where these treatments cannot be offered or are not received in time," said Professor Jenkins.

https://medicalxpress.com/news/2021-05-weve-covid-pneumonia.html

But but but, enjoy the CYDY show...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News